It's a New Day in Public Health.
The Florida Department of Health works to protect, promote & improve the health of all people in Florida through integrated state, county & community efforts.
The ADAP drug formulary is a listing of all medications that are covered by the program for all eligible clients, whether insured or uninsured. If a medication is not listed on the drug formulary, then the insurance or assistance program will not cover the medication costs.
Trogarzo® (ibalizumab-uiyk) is a first-in-class CD4-directed post-attachment HIV-1 inhibitor for people living with HIV infection who have tried multiple HIV medications in the past and whose HIV infection has not been successfully treated with other currently available therapies. Trogarzo® is administered intravenously once every 14 days by a medical professional and must be used in combination with an optimized background regimen containing one or more antiretrovirals with activity against the virus.
Trogarzo® is available to a limited number of eligible ADAP clients through a prior authorization (PA) process sent to the department’s medical team and access will be coordinated through Thera technologies’ distribution network for ADAP clients.